CLINICAL TRIALS PROFILE FOR OCRIPLASMIN
✉ Email this page to a colleague
All Clinical Trials for ocriplasmin
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00412451 ↗ | A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME) | Completed | ThromboGenics | Phase 2 | 2006-12-01 | A multicenter study to compare multiple doses of intravitreal microplasmin for non-surgical PVD induction for treatment of patients with DME. |
NCT00435539 ↗ | A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction (MIVI-IIt) | Completed | ThromboGenics | Phase 2 | 2007-02-01 | A multicenter study to compare multiple doses of intravitreal microplasmin for non-surgical PVD induction for treatment of patients with vitreomacular traction. |
NCT00913744 ↗ | Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion | Completed | ThromboGenics | Phase 2 | 2010-01-01 | This study will evaluate the safety and efficacy of Ocriplasmin intravitreal injection, in subjects diagnosed with exudative AMD with focal vitreomacular adhesion. Ultimately, it is believed that intravitreal ocriplasmin may offer physicians a safe agent for pharmacologic vitreolysis and nonsurgical resolution of focal vitreomacular adhesion in AMD subjects where this adhesion may be causally associated with worse prognosis). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ocriplasmin
Condition Name
Clinical Trial Locations for ocriplasmin
Trials by Country
Clinical Trial Progress for ocriplasmin
Clinical Trial Phase
Clinical Trial Sponsors for ocriplasmin
Sponsor Name